Müllerian-inhibiting substance in women with polycystic ovary syndrome: Relationship with hormonal and metabolic characteristics
- 1 October 2004
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 82 (4), 970-972
- https://doi.org/10.1016/j.fertnstert.2004.06.001
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Serum müllerian-inhibiting substance levels during normal menstrual cyclesFertility and Sterility, 2000
- Metformin treatment reduces ovarian cytochrome P-450c17α response to human chorionic gonadotrophin in women with insulin resistance-related polycystic ovary syndromeHuman Reproduction, 2000
- Control of Primordial Follicle Recruitment by Anti-Müllerian Hormone in the Mouse Ovary1Endocrinology, 1999
- Decreases in Ovarian Cytochrome P450c17α Activity and Serum Free Testosterone after Reduction of Insulin Secretion in Polycystic Ovary SyndromeNew England Journal of Medicine, 1996
- Anti-müllerian hormone and anti-müllerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth.Endocrinology, 1995
- Ontogeny of Reproductive Abnormalities Induced by Deregulation of Anti-Müllerian Hormone Expression in Transgenic MiceBiology of Reproduction, 1995
- An Immunoassay to Detect Human Mullerian Inhibiting Substance in Males and Females during Normal Development*Journal of Clinical Endocrinology & Metabolism, 1990
- Isolation of the bovine and human genes for müllerian inhibiting substance and expression of the human gene in animal cellsCell, 1986
- Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in manDiabetologia, 1985
- Continuous infusion of glucose with model assessment: measurement of insulin resistance and ?-cell function in manDiabetologia, 1985